BNP Paribas Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.59M | Sell |
93,916
-27,811
| -23% | -$766K | 0.01% | 676 |
|
|
2025
Q1 | $3.46M | Buy |
121,727
+48,529
| +66% | +$1.38M | 0.01% | 609 |
|
|
2024
Q4 | $3.04M | Sell |
73,198
-12,275
| -14% | -$510K | 0.01% | 645 |
|
|
2024
Q3 | $5.71M | Buy |
85,473
+29,177
| +52% | +$1.95M | 0.01% | 519 |
|
|
2024
Q2 | $6.69M | Sell |
56,296
-37,172
| -40% | -$4.41M | 0.02% | 484 |
|
|
2024
Q1 | $9.96M | Sell |
93,468
-205,609
| -69% | -$21.9M | 0.03% | 430 |
|
|
2023
Q4 | $29.7M | Buy |
299,077
+242,781
| +431% | +$24.1M | 0.08% | 248 |
|
|
2023
Q3 | $5.82M | Buy |
56,296
+12,131
| +27% | +$1.25M | 0.02% | 490 |
|
|
2023
Q2 | $5.37M | Buy |
44,165
+1,100
| +3% | +$134K | 0.02% | 505 |
|
|
2023
Q1 | $6.61M | Sell |
43,065
-35,971
| -46% | -$5.52M | 0.02% | 483 |
|
|
2022
Q4 | $14.2M | Sell |
79,036
-16,009
| -17% | -$2.88M | 0.05% | 370 |
|
|
2022
Q3 | $11.2M | Sell |
95,045
-34,234
| -26% | -$4.05M | 0.04% | 392 |
|
|
2022
Q2 | $18.5M | Sell |
129,279
-84,138
| -39% | -$12M | 0.07% | 295 |
|
|
2022
Q1 | $36.8M | Buy |
213,417
+87,758
| +70% | +$15.1M | 0.13% | 196 |
|
|
2021
Q4 | $31.9M | Buy |
125,659
+51,353
| +69% | +$13M | 0.11% | 234 |
|
|
2021
Q3 | $28.6M | Buy |
74,306
+51,308
| +223% | +$19.7M | 0.11% | 228 |
|
|
2021
Q2 | $5.41M | Buy |
22,998
+16,668
| +263% | +$3.92M | 0.02% | 534 |
|
|
2021
Q1 | $829K | Buy |
6,330
+170
| +3% | +$22.3K | ﹤0.01% | 739 |
|
|
2020
Q4 | $644K | Sell |
6,160
-634
| -9% | -$66.3K | ﹤0.01% | 742 |
|
|
2020
Q3 | $481K | Sell |
6,794
-40
| -0.6% | -$2.83K | ﹤0.01% | 745 |
|
|
2020
Q2 | $439K | Buy |
+6,834
| New | +$439K | ﹤0.01% | 708 |
|